5-乙氧基-1,3-苯并噻唑-2-胺 | 70066-70-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 5-乙氧基-1,3-苯并噻唑-2-胺
• 英文名称: 5-ethoxybenzo[d]thiazol-2-amine
• 英文别名: 6-ethoxy-2-aminobenzothiazole；5-ethoxy-benzothiazol-2-ylamine；6-Ethoxy-2-amino-benzthiazol；5-ethoxy-1,3-benzothiazol-2-amine
• CAS: 70066-70-5
• 化学式: C₉H₁₀N₂OS
• mdl: MFCD05664563
• 分子量: 194.257
• InChiKey: MNJJTXUPEWJFRC-UHFFFAOYSA-N

物化性质

• 沸点：
  356.1±34.0 °C(Predicted)
• 密度：
  1.303±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  76.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  5-乙氧基-1,3-苯并噻唑-2-胺 在 potassium carbonate 、 三乙胺 作用下， 以 甲苯 为溶剂， 生成 4-amino-5-[2-(4-hydroxyphenyl)ethyl]-3-[N-(6-ethoxylbenzothiazole-2-yl)acetamido]thio-4H-1,2,4-triazole
  参考文献：
  名称：

  Synthesis of Some Novel Triazole Derivatives and Investigation of Their Antimicrobial Activities

  摘要：

  [image omitted] The aim of this study is to synthesize new triazole derivatives and investigate their antimicrobial activities. 4-Amino-5-(2-cyclohexylethyl)-3-[N-(benzothiazole-2-yl)acetamido]thio-4H-1,2,4-triazole and 4-amino-5-[2-(4-hydroxyphenyl)ethyl]-3-[N-(benzothiazole-2-yl)acetamido]thio-4H-1,2,4-triazole derivatives were prepared by the reaction of 2-chloro-N-(benzothiazole-2-yl)acetamides with 4-amino-5-(2-cyclohexylethyl)-2,4-dihydro-3H-1,2,4-triazol-3-thione and 4-amino-5-[2-(4-hydroxyphenyl)ethyl]-2,4-dihydro-3H-1,2,4-triazol-3-thione, respectively. The structures of these compounds were elucidated by infrared, 1H NMR, 13C NMR, mass spectra, and elemental analysis. The synthesized compounds were screened for their antimicrobial activities against various Candida species and pathogenic bacteria. Compound IIIg and compound IIIi were found to be the most potent derivatives against Candida species and tested bacteria, respectively.

  DOI：

  10.1080/00397911.2010.501475

文献信息

• Therapeutic heterocyclic compounds
  申请人：——

  公开号：US20030013708A1

  公开（公告）日：2003-01-16

  Provided herein is a compound having the formula (I): 1 Wherein said compounds are useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT 1B and 5HT 1D antagonists.

  本文提供的化合物具有以下式（I）： 其中所述化合物可用于治疗精神障碍，包括但不限于抑郁症、广泛性焦虑、进食障碍、痴呆症、恐慌障碍和睡眠障碍。这些化合物还可能用于治疗胃肠道障碍、心血管调节、运动障碍、内分泌障碍、血管痉挛和性功能障碍。这些化合物是5HT 1B和5HT 1D拮抗剂。
• Therapeutic chromone compounds
  申请人：——

  公开号：US20040087575A1

  公开（公告）日：2004-05-06

  Provided herein is a compound of the formula (I) wherein said compound is useful for the treatment of psychiatric disorders including but not limited to depression, generalized anxiety, eating, disorders, dementia, panic disorder, and sleep disorders. The compounds may also be useful in the treatment of gastrointestinal disorders, cardiovascular regulation, motor disorders, endocrine disorders, vasospasm and sexual dysfunction. The compounds are 5HT 1B antagonists. Also provided herein are processes for making compounds of Formula (I) and intermediate compounds.

  本文提供的是一种化合物，其化学式为（I），其中该化合物可用于治疗包括但不限于抑郁症、广泛性焦虑、进食障碍、痴呆症、恐慌障碍和睡眠障碍在内的精神疾病。这些化合物也可能对治疗胃肠道疾病、心血管调节、运动障碍、内分泌失调、血管痉挛和性功能障碍有用。这些化合物是5HT 1B 拮抗剂。本文还提供了制备化合物（I）和中间体化合物的方法。
• Therapeutic chroman compounds
  申请人：——

  公开号：US20040110745A1

  公开（公告）日：2004-06-10

  Provided herein is a compound represented by the Formula (I) wherein said compounds are useful for the treatment of migraine. Also provided are processes for the preparation of compounds of Formula (I) and intermediates.

  本文提供的是一种化合物，其化学式表示为（I），其中这些化合物对治疗偏头痛有用。还提供了制备化合物（I）和中间体的方法。
• Ligand-free Iron(II)-Catalyzed N-Alkylation of Hindered Secondary Arylamines with Non-activated Secondary and Primary Alcohols <i>via</i> a Carbocationic Pathway
  作者：Onkar S. Nayal、Maheshwar S. Thakur、Manoranjan Kumar、Neeraj Kumar、Sushil K. Maurya

  DOI：10.1002/adsc.201701183

  日期：2018.2.15

  Secondary benzylic alcohols represent a challenging class of substrates for N‐alkylation of amines. Herein, we describe an iron(II)‐catalyzed eco‐friendly protocol for N‐alkylation of secondary arylamines with secondary benzyl alcohols through a carbocationic pathway instead of the known borrowing hydrogen transfer (BHT) approach. Transiently generated carbocations, produced from alcohols via self‐condensation

  仲苄醇代表胺N-烷基化的一类具有挑战性的底物。本文中，我们描述了一种铁（II）催化的生态友好方案，用于通过碳阳离子途径而不是已知的借位氢转移（BHT）方法，将仲芳基胺与仲苄醇进行N-烷基化。由醇通过自缩合反应产生的瞬态碳正离子与芳基胺偶合，以提供高度官能化的胺产物。该方法的范围涉及伯，仲和杂环胺与伯/仲苄基，烯丙基和杂环醇的N-烷基化，这是许多药物中常见的关键结构。该方法也可以容易地用于各种天然产物的胺化。
• [EN] PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME<br/>[FR] DÉRIVÉ DE BENZOTHIAZOLE CONTENANT PHÉNYLIMIDE OU SON SEL ET COMPOSITION PHARMACEUTIQUE LE COMPRENANT
  申请人：YUHAN CORP

  公开号：WO2013043001A1

  公开（公告）日：2013-03-28

  The present invention provides a phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.

  本发明提供了一种含有苯甲酰亚胺基的苯并噻唑衍生物或其药用可接受盐，以及其制备方法和包含其的药物组合物。所述含有苯甲酰亚胺基的苯并噻唑衍生物或其药用可接受盐可以选择性地抑制KRS和层粘连蛋白受体（LR）之间的蛋白质相互作用，从而抑制癌细胞的迁移。因此，含有苯甲酰亚胺基的苯并噻唑衍生物或其药用可接受盐可能被有益地应用于预防或治疗与癌细胞转移相关的疾病。